Human SERPINC1/AT3/AT3D ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_000488.3)
Cat. No.: pGMAAV000297
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human SERPINC1/AT3/AT3D Adeno-associated virus expression plasmid (ITR-vector) for SERPINC1 AAV packaging, SERPINC1 AAV production.The purified Human SERPINC1/AT3/AT3D AAV particle serves as an invaluable asset for in-depth in vivo SERPINC1 studies, mechanism of action (MOA) research, and the evolution of SERPINC1-associated gene therapy strategies.
Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.
Go to
ATIII/SERPINC1/AT3 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMAAV000297 |
Gene Name | SERPINC1 |
Accession Number | NM_000488.3 |
Gene ID | 462 |
Species | Human |
Product Type | Adeno-associate virus(AAV) plasmid (overexpression) |
Insert Length | 1395 bp |
Gene Alias | AT3,AT3D,ATIII,ATIII-R2,ATIII-T1,ATIII-T2,THPH7 |
Fluorescent Reporter | Firefly luciferase |
Mammalian Cell Selection | Null |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | TBG |
Resistance | Amplicin |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-T73476-Ab | Anti-ANT3/ ATIII/ SERPINC1 monoclonal antibody |
Target Antigen | GM-Tg-g-T73476-Ag | ATIII/SERPINC1 VLP (virus-like particle) |
ORF Viral Vector | pGMLP002891 | Human SERPINC1 Lentivirus plasmid |
ORF Viral Vector | pGMAAV000149 | Human SERPINC1 Adeno-associate virus(AAV) plasmid |
ORF Viral Vector | pGMAAV000297 | Human SERPINC1 Adeno-associate virus(AAV) plasmid |
ORF Viral Vector | pGMAAV000501 | Human SERPINC1 Adeno-associate virus(AAV) plasmid |
ORF Viral Vector | vGMLP002891 | Human SERPINC1 Lentivirus particle |
ORF Viral Vector | vGMAAV000149 | Human SERPINC1 Adeno-associate virus(AAV) particle |
ORF Viral Vector | vGMAAV000297 | Human SERPINC1 Adeno-associate virus(AAV) particle |
ORF Viral Vector | vGMAAV000501 | Human SERPINC1 Adeno-associate virus(AAV) particle |
Target information
Target ID | GM-T73476 |
Target Name | ATIII |
Gene ID | 462, 11905, 708854, 304917, 101093983, 480066, 540261, 100061173 |
Gene Symbol and Synonyms | At-3,AT3,AT3D,ATIII,ATIII-R2,ATIII-T1,ATIII-T2,SERPINC1,THPH7 |
Uniprot Accession | P01008 |
Uniprot Entry Name | ANT3_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target |
Disease | Not Available |
Gene Ensembl | ENSG00000117601 |
Target Classification | Not Available |
The protein encoded by this gene, antithrombin III, is a plasma protease inhibitor and a member of the serpin superfamily. This protein inhibits thrombin as well as other activated serine proteases of the coagulation system, and it regulates the blood coagulation cascade. The protein includes two functional domains: the heparin binding-domain at the N-terminus of the mature protein, and the reactive site domain at the C-terminus. The inhibitory activity is enhanced by the presence of heparin. Numerous mutations have been identified for this gene, many of which are known to cause antithrombin-III deficiency which constitutes a strong risk factor for thrombosis. A reduction in the serum level of this protein is associated with severe cases of Coronavirus Disease 19 (COVID-19). [provided by RefSeq, Sep 2020]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.